BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 11416144)

  • 1. ZBP-89 promotes growth arrest through stabilization of p53.
    Bai L; Merchant JL
    Mol Cell Biol; 2001 Jul; 21(14):4670-83. PubMed ID: 11416144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ZBP-89 mediates butyrate regulation of gene expression.
    Merchant JL; Bai L; Okada M
    J Nutr; 2003 Jul; 133(7 Suppl):2456S-2460S. PubMed ID: 12840224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcription factor ZBP-89 cooperates with histone acetyltransferase p300 during butyrate activation of p21waf1 transcription in human cells.
    Bai L; Merchant JL
    J Biol Chem; 2000 Sep; 275(39):30725-33. PubMed ID: 10899165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mdm2 inhibition of p53 induces E2F1 transactivation via p21.
    Wunderlich M; Berberich SJ
    Oncogene; 2002 Jun; 21(28):4414-21. PubMed ID: 12080472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between ZBP-89 and p53 mutants and its contribution to effects of HDACi on hepatocellular carcinoma.
    Zhang CZ; Chen GG; Merchant JL; Lai PB
    Cell Cycle; 2012 Jan; 11(2):322-34. PubMed ID: 22214764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation of p53 in recurrent hepatocellular carcinoma and its association with the expression of ZBP-89.
    Chen GG; Merchant JL; Lai PB; Ho RL; Hu X; Okada M; Huang SF; Chui AK; Law DJ; Li YG; Lau WY; Li AK
    Am J Pathol; 2003 Jun; 162(6):1823-9. PubMed ID: 12759240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. YY1 inhibits the activation of the p53 tumor suppressor in response to genotoxic stress.
    Grönroos E; Terentiev AA; Punga T; Ericsson J
    Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12165-70. PubMed ID: 15295102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P53 mutants suppress ZBP-89 function.
    Okada M; Tessier A; Bai L; Merchant JL
    Anticancer Res; 2006; 26(3A):2023-8. PubMed ID: 16827139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recruitment of ataxia-telangiectasia mutated to the p21(waf1) promoter by ZBP-89 plays a role in mucosal protection.
    Bai L; Kao JY; Law DJ; Merchant JL
    Gastroenterology; 2006 Sep; 131(3):841-52. PubMed ID: 16952553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional interplay between p53 and E2F through co-activator p300.
    Lee CW; Sørensen TS; Shikama N; La Thangue NB
    Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective transcription of p53 target genes by zinc finger-p53 DNA binding domain chimeras.
    Falke D; Fisher MH; Juliano RL
    Biochim Biophys Acta; 2004 Nov; 1681(1):15-27. PubMed ID: 15566940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The MDM2 RING-finger domain is required to promote p53 nuclear export.
    Geyer RK; Yu ZK; Maki CG
    Nat Cell Biol; 2000 Sep; 2(9):569-73. PubMed ID: 10980696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcription factor ZBP-89 in cancer growth and apoptosis.
    Zhang CZ; Chen GG; Lai PB
    Biochim Biophys Acta; 2010 Aug; 1806(1):36-41. PubMed ID: 20230874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MdmX protects p53 from Mdm2-mediated degradation.
    Jackson MW; Berberich SJ
    Mol Cell Biol; 2000 Feb; 20(3):1001-7. PubMed ID: 10629057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MDM2 interaction with nuclear corepressor KAP1 contributes to p53 inactivation.
    Wang C; Ivanov A; Chen L; Fredericks WJ; Seto E; Rauscher FJ; Chen J
    EMBO J; 2005 Sep; 24(18):3279-90. PubMed ID: 16107876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of p53 by hypoxia: dissociation of transcriptional repression and apoptosis from p53-dependent transactivation.
    Koumenis C; Alarcon R; Hammond E; Sutphin P; Hoffman W; Murphy M; Derr J; Taya Y; Lowe SW; Kastan M; Giaccia A
    Mol Cell Biol; 2001 Feb; 21(4):1297-310. PubMed ID: 11158315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of p53-dependent apoptosis by acute ablation of glycogen synthase kinase-3beta in colorectal cancer cells.
    Ghosh JC; Altieri DC
    Clin Cancer Res; 2005 Jun; 11(12):4580-8. PubMed ID: 15958644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis.
    Tang Y; Luo J; Zhang W; Gu W
    Mol Cell; 2006 Dec; 24(6):827-39. PubMed ID: 17189186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac transcription factor Nkx2.5 interacts with p53 and modulates its activity.
    Kojic S; Nestorovic A; Rakicevic L; Protic O; Jasnic-Savovic J; Faulkner G; Radojkovic D
    Arch Biochem Biophys; 2015 Mar; 569():45-53. PubMed ID: 25677450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of Mdm2 and MdmX fusion proteins alters p53 mediated transactivation, ubiquitination, and degradation.
    Ghosh M; Huang K; Berberich SJ
    Biochemistry; 2003 Mar; 42(8):2291-9. PubMed ID: 12600196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.